Genenta is a clinical stage immuno oncology-company
NYC and Milan
- Tweets 43
- Following 12
- Followers 280
- Likes 66
Join us Innovit for Life Sciences July 11 8.30amPDT/5.30pmCET @pigiparacchi @GenentaScience (@Nasdaq:GNTA) @MiraChaurushiya @BioWestlake @SergioAbrignani @niaforg @NucleateHQ @issnaf @innovitsf @AssobiotecNews @Farmindustria bit.ly/3JBgL0Z
1
1
4
633
Join us Innovit for Life Sciences July 11 8.30amPDT/5.30pmCET
@pigiparacchi @GenentaScience (@Nasdaq:GNTA) @MiraChaurushiya @BioWestlake
@SergioAbrignani
@niaforg @NucleateHQ @issnaf @assoiotecnews @innovitsf @AssobiotecNews @Farmindustria bit.ly/3JBgL0Z
2
2
4
765
Join us for a live session that brings together the competitiveness of Italian Life Sciences and the experience of US Investors.
Innovit for Life Sciences > Road to #JPM24
On Tuesday 27th June 2023 10.30am EDT - 4.30pm CET
@GenentaScience @AssobiotecF
1
1
5
226
Our lead candidate is a lenti-virus based hematopoietic stem progenitor cell #immunotherapy enabling controlled and targeted interferon-α expression within #cancers. Learn more: bit.ly/3VGjoT3
2
2
184
At Genenta, our scientists bring a unique blend of multi-disciplinary competence, vast experience in #CellTherapy, and a commensurate track-record in the forefront of therapies and #DrugDevelopment. Learn more: bit.ly/40xHqBL
1
1
144
Meet Richard B. Slansky, Chief Financial Officer at Genenta! Richard is a senior financial executive with more than 30 years of experience at various #biopharmaceutical diagnostic and life science companies. Learn more: bit.ly/3ZV3yGf
1
1
2
319
Our platform technology triggers the production of alpha-interferon as a therapeutic inside the tumors through a transgene expression control vector, allowing for a robust anti-cancer response with potential minimized systemic toxicity. Check out our MOA: bit.ly/3FXShxs
1
4
173
Meet Carlo Russo, M.D., our Chief Medical Officer & Head of Development! Carlo is a #biotech executive with vast experience in research & development in large pharma companies and holds a number of senior positions at research institutions. Learn more: bit.ly/3ZV3yGf
2
1
1
125
Our team is comprised of knowledgeable personnel whose in-depth experience is vast across the cell and gene therapy space. We select the most advantageous team members across the globe. Learn more: bit.ly/3mKmDwh
1
1
130
This #InternationalWomensDay, join us as we #EmbraceEquality and celebrate the hard work of Genenta’s fierce female team members – Stefania Mazzoleni, Valentina Brambilla, and Barbara Regonini – who strive for excellence every day. Learn more: bit.ly/36z1MnO @womensday
2
1
2
180
Our proprietary cell-based platform allows the controlled expression of various cytokines by Tie-2 expressing monocytes, enabling the delivery of targeted & controlled treatment of any TEMs-expressing tumors while potentially minimizing systemic toxicities bit.ly/3xQ8Zdq
1
1
3
150
Here at Genenta, we are developing a platform to address unmet immuno-oncology needs to deliver potential treatments for solid tumors. Learn more about us and our platform here: bit.ly/3HiUuEM $GNTA
1
3
667
#DYK glioblastoma multiforme (GBM) is one of the most malignant types of central nervous system tumors? Despite advances in treatment modalities, it remains largely incurable. Learn how we're addressing the unmet need in this space: bit.ly/3HgqGs2
1
2
154
We are excited to be attending the @jpmorgan Healthcare Conference! Join us Jan 11 at 5:00 PM CT for #ItalyOnTheMove, an exclusive event to network with industry partners & discuss the Italian pharma/biotech market. Learn more and register here: bit.ly/3Zfesa3 #JPM2023
2
5
974
With an initial clinical focus on solid tumors with major unmet needs, Genenta’s platform of autologous oncology products is advancing through preclinical and clinical assessment. Learn more about our pipeline: bit.ly/3VGjoT3
1
2
Genenta is a clinical stage immune oncology-company developing a cell-based platform harnessing the power of hematopoietic stem cells to provide durable and safe treatments for solid tumors. To learn more about who we are, visit: bit.ly/3OKW5VE
1
2
#BioInItaly Investment Forum is the key investment forum for biotech & life sciences innovation in Italy. Join us Dec 5 230pm CET at @CariploFactory @AssobiotecNews Luca Pagetti Bill Barber @intesasanpaolo IndacoVenture Partners Elizabeth Robinson @pigiparacchi @GenentaScience
1
4
@Genenta is joining @NucleateHQ Italy event
Nov 26th 2022 at 2:00 p.m.
#biotech Venture and investments session @pigiparacchi CEO and Co-founder @Genenta, @rikisabatini (@OrionisBio ) and Luca Benatti (#EryDel S.p.A.) and @MassimoMLucidi
4
6
@AssobiotecF dal ciclo "Gli strumenti finanziari per lo sviluppo di #Startup e #PMI #biotech".
@pigiparacchi del Consiglio di Presidenza, coordinatore Gruppo di lavoro PMI, CEO @GenentaScience intervista @CiroSpedaliere Co-founder e Managing partner @ClarisVentures
1
2
#BowlingGreenBull an initiative of American Chamber of Commerce in Italy in collaboration with @Nasdaq @Genenta Science @docebo @kaleyra presents
Navigating volatile capital markets
Live Webinar
Nov 15th - 4pmCET
1
4
Pierluigi Paracchi, CEO and Co-founder Genenta Science, was at Techchill International startup & tech event Milan for "Founder Stories" fireside chat a deep dive into the key learnings of a success story.
piped.video/watch?v=RZ43ldn6…
1
3